Didier Blaise

Trials

Studies that name Didier Blaise as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:32 UTC. Open this list on ClinicalTrials.gov

• N/A
  NCT05486273 · Evaluation of the Impact of Sports-inspired Onco-coaching on Health-related Quality's Life of the Patients in Cancer Remission After Allogeneic Transplantation of Hematopoietic Stem Cells

  Institut Paoli-Calmettes · unknown · Hematological Cancer · principal investigator
• Ph3
  NCT03595800 · Extension of a Study of Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor to Younger Patients Eligible for Reduced-intensity Conditioning Regimen

  Institut Paoli-Calmettes · completed · Acute Leukemia, Non Hodgkin Lymphoma, Multiple Myeloma · principal investigator
• Ph2
  NCT02966301 · Treatment of Chronic Graft Versus Host Disease With Arsenic Trioxide

  Medsenic · completed · Chronic Graft-Versus-Host Disease, Immune System Diseases · principal investigator
• Ph1
  NCT02921685 · Study of a Humanized Antibody Initiated 2 Months After an HLA Matched Allogenic Stem Cell Transplantation

  Institut Paoli-Calmettes · unknown · Hematologic Malignancies · principal investigator
• Ph3
  NCT02623309 · Studyof Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor in Elderly Patients

  Institut Paoli-Calmettes · completed · Hematologic Neoplasms · principal investigator
• Ph2
  NCT01985061 · Evaluation of 3 Different Doses of IV Busulfan

  Institut Paoli-Calmettes · completed · Myelodysplastic Syndrome, Acute Myeloid Leukemia · principal investigator
• Ph1/Ph2
  NCT01819558 · Phase I/II Study of Immune Therapy After Allograft in Patients With Myeloid Hemopathy

  Institut Paoli-Calmettes · completed · Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Myelodysplastic Syndrome · principal investigator
• Ph2
  NCT01135641 · Study of First Line Treatment of Chronic Graft Versus Host Disease With the Association of Ciclosporine, Corticosteroids and Rituximab (Protocol R-GVHD)

  Nantes University Hospital · completed · Graft Versus Host Disease · study chair
• Ph2
  NCT00894049 · A Study Comparing Non Myeloablative (Flu-TBI) and Reduced Intensity (FLU-BU-ATG) Conditioning in Allogenic Transplantation

  Institut Paoli-Calmettes · completed · Allograft, Allogeneic Cell Transplantaion, Hematological Malignancy · principal investigator
• Ph2
  NCT00806767 · Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological Cancer

  Institut Paoli-Calmettes · completed · Chronic Myeloproliferative Disorders, Leukemia, Lymphoma · unknown
• Ph2
  NCT00802568 · Fludarabine, Busulfan, Antithymocyte Globulin, and Donor Stem Cell Transplant in Treating Patients With Multiple Myeloma That Has Not Responded to Treatment

  Institut Paoli-Calmettes · completed · Multiple Myeloma and Plasma Cell Neoplasm · unknown
• Ph2
  NCT00740467 · Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders

  Institut Paoli-Calmettes · unknown · Graft Versus Host Disease, Leukemia, Lymphoma · study chair
• Ph2
  NCT00056095 · Allogeneic Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer

  UNICANCER · completed · Kidney Cancer · study chair

Grants

NIH projects from RePORTER, fetched 2026-11-12 11:32 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.